MUC1 and breast cancer: Wu et al. developed an mAb targeting MUC1-C (hMUC1), which recognized recombinant MUC1 as well as natural MUC1-C in BC cells, and hMUC1 significantly inhibited BC cell proliferation in vivo [176].